The European Academy of Gynaecological Surgery

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1016/j.ejca.2021.08.023 Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer
https://doi.org/10.1186/s40425-015-0102-0 The dark side of ID8-Luc2: pitfalls for luciferase tagged murine models for ovarian cancer
https://doi.org/10.1097/igc.0000000000000478 European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Industry Partners—First Update 2015
https://doi.org/10.1038/s41416-022-02108-7 INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
https://doi.org/10.1007/s10459-019-09910-8 From prescription to guidance: a European framework for generic competencies
https://doi.org/10.1016/j.annonc.2020.08.2262 LBA32 Tisotumab vedotin in previously treated recurrent or metastatic cervical cancer: Results from the phase II innovaTV 204/GOG-3023/ENGOT-cx6 study
https://doi.org/10.1002/uog.24879 How to use power Doppler ultrasound in transvaginal assessment of uterine fibroids
Excellence needs training "Certified programme in endoscopic surgery".
https://doi.org/10.1200/jco.2022.40.16_suppl.5507 Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205.
https://doi.org/10.1016/j.ygyno.2023.01.003 Randomized phase II trial of farletuzumab plus chemotherapy versus placebo plus chemotherapy in low CA-125 platinum-sensitive ovarian cancer
https://doi.org/10.1158/1078-0432.ccr-23-0621 Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer
https://doi.org/10.1016/j.ejogrb.2016.10.004 The current situation of infertility services provision in Europe
https://doi.org/10.3389/fped.2021.721257 SARS-CoV-2 Vaccination in Children and Adolescents—A Joint Statement of the European Academy of Paediatrics and the European Confederation for Primary Care Paediatricians
https://doi.org/10.1200/jco.2022.40.16_suppl.5512 Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Characterization of antitumor activity in the SORAYA study.
https://doi.org/10.1002/pd.5702 SARS‐CoV2 (COVID‐19) infection: is fetal surgery in times of national disasters reasonable?
https://doi.org/10.1007/s00431-017-3055-0 European Antibiotic Awareness Day 2017: training the next generation of health care professionals in antibiotic stewardship
https://doi.org/10.3389/fped.2021.758415 Increasing the Focus on Children's Complex and Integrated Care Needs: A Position Paper of the European Academy of Pediatrics
https://doi.org/10.1016/j.ygyno.2022.06.028 Impact of disease progression on health-related quality of life of advanced ovarian cancer patients – Pooled analysis from the PRIMA trial
https://doi.org/10.1016/j.gore.2017.01.002 Ovarian cancer and the immune system
https://doi.org/10.1016/j.ejogrb.2022.03.009 Provision of antenatal care in Europe-A scientific study commissioned by European Board and College of Obstetrics and Gynaecology (EBCOG)
https://doi.org/10.1136/ijgc-2019-igcs.1 1 MILO/ENGOT-OV11: Phase-3 study of binimetinib versus physician’s choice chemotherapy (PCC) in recurrent or persistent low-grade serous carcinomas of the ovary, fallopian tube, or primary peritoneum
https://doi.org/10.1016/j.jocn.2021.01.026 European women in neurosurgery: I – A chronology of trailblazers
https://doi.org/10.3390/cancers13081939 Age- and Intravenous Methotrexate-Associated Leukoencephalopathy and Its Neurological Impact in Pediatric Patients with Lymphoblastic Leukemia
https://doi.org/10.1016/j.annonc.2022.07.658 530P PRIMA/ENGOT-OV26/GOG-3012 study: Updated long-term PFS and safety
https://doi.org/10.1111/all.15855 UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan
https://doi.org/10.1016/j.annonc.2021.08.1166 723MO Tisotumab vedotin (TV) + carboplatin (Carbo) in first-line (1L) or + pembrolizumab (Pembro) in previously treated (2L/3L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT-Cx8/GOG-3024/innovaTV 205 study
https://doi.org/10.1111/jdv.18982 Position statement: Recommendations on the diagnosis and treatment of Malassezia folliculitis
https://doi.org/10.3389/fped.2023.1125958 Sport activities for children and adolescents: the Position of the European Academy of Paediatrics and the European Confederation of Primary Care Paediatricians 2023—Part 1. Pre-participation physical evaluation in young athletes
https://doi.org/10.1111/pai.14080 Asthma and rhinitis control in adolescents and young adults: A real‐world MASK ‐air study
https://doi.org/10.1136/ijgc-2023-005189 A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial
https://doi.org/10.1200/jco.2021.39.15_suppl.tps5607 Uplift (ENGOT-ov67): A pivotal cohort to evaluate XMT-1536 (upifitamab rilsodotin), a NaPi2b-directed antibody drug conjugate for platinum-resistant ovarian cancer.
https://doi.org/10.3389/fped.2024.1298884 European Academy of Paediatrics statement on the clinical management of children and adolescents with gender dysphoria
https://doi.org/10.1097/j.pbj.0000000000000199 Candidates selection for oocyte donation in a public gamete bank—Predictive value of the anti-Müllerian hormone
https://doi.org/10.1080/13543784.2023.2179483 Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
https://doi.org/10.1016/j.ygyno.2023.04.028 Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer
https://doi.org/10.3389/fped.2024.1333239 Over-investigation and overtreatment in pediatrics: a survey from the European Academy of Paediatrics and Japan Pediatric Society
https://doi.org/10.1093/bioinformatics/btae522 MetDecode: methylation-based deconvolution of cell-free DNA for noninvasive multi-cancer typing
https://doi.org/10.3389/fped.2021.580150 COVID-19 and the Use of Masks by Children. Statement From the Association of Schools of Public Health in the European Region and the European Academy of Paediatrics
https://doi.org/10.3389/ijph.2021.1604010 COVID-19 Containment Measures at Childcare and Schools in 19 European Countries: An Observational Study on Local, Federal and National Policies
https://doi.org/10.1158/1078-0432.ccr-22-3645 Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features
https://doi.org/10.1136/ijgc-2024-005356 Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study
https://doi.org/10.1016/j.annonc.2025.04.011 Long-term development of 12- and 15-year-old offspring after maternal cancer diagnosis during pregnancy: a prospective multicentre cohort study
https://doi.org/10.3390/cancers15225428 Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors—Results of Expression VI–Carolin Meets HANNA–Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG Survey
https://doi.org/10.1016/s2352-4642(24)00075-0 Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy: a multicentre cohort study of the International Network on Cancer, Infertility, and Pregnancy
https://doi.org/10.1016/j.ejca.2025.115306 Tumor Treating Fields therapy in platinum-resistant ovarian cancer: Results of the ENGOT-ov50/GOG-3029/INNOVATE-3 pivotal phase 3 randomized study
https://doi.org/10.1016/j.annonc.2023.10.410 288MO InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer
https://doi.org/10.3389/fped.2023.1264829 Digital child health: opportunities and obstacles. A joint statement of European Academy of Paediatrics and European Confederation of Primary Care Paediatricians
https://doi.org/10.1016/j.ygyno.2024.07.006 Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease after first-line chemotherapy: An ad hoc subgroup analysis of PRIMA/ENGOT-OV26/GOG-3012
https://doi.org/10.1080/17434440.2024.2404257 Orphan and paediatric medical devices in Europe: recommendations to support their availability for on-label and off-label clinical indications
https://doi.org/10.1016/j.eclinm.2024.102922 Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study
https://doi.org/10.3389/fped.2022.806399 Adolescents With Eating Disorders in Pediatric Practice – The European Academy of Paediatrics Recommendations
https://doi.org/10.1016/j.ejogrb.2024.10.042 Vaginal erbium laser versus pelvic floor exercises for the treatment of pelvic organ prolapse: A randomised controlled trial
https://doi.org/10.1016/j.cgh.2025.02.010 Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis
https://doi.org/10.1002/ijgo.70577 Paracetamol (acetaminophen) use during pregnancy and autism risk: Evidence does not support causal association
https://doi.org/10.1016/j.esmoop.2024.103540 40MO First-line (1L) durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib for endometrial cancer (EC) (DUO-E): Objective response rate (ORR), duration of response (DoR) and time to treatment discontinuation or death (TDT) by mismatch repair (MMR) status
https://doi.org/10.1111/apa.17393 European paediatricians need to be more aware of the risks faced by children who swallow button batteries and how to treat them
https://doi.org/10.1016/j.ijgc.2025.101703 Durvalumab Plus Carboplatin/Paclitaxel Followed By Durvalumab With/Without Olaparib In Endometrial Cancer: Exploratory Analyses Of Histology, Biomarker Heterogeneity And Efficacy In The DUO-E Mismatch Repair Proficient Subpopulation
https://doi.org/10.1016/j.bjps.2025.04.003 Fat-augmented latissimus dorsi flap and implant-based latissimus dorsi flap: A systematic review
https://doi.org/10.1016/j.ejogrb.2025.113979 How to influence rising caesarean section rates in Europe? An invited scientific review by European Board and College of Obstetrics and Gynaecology (EBCOG)
https://doi.org/10.1200/jco.2025.43.16_suppl.5563 Circulating tumor DNA (ctDNA) monitoring in participants (pts) with ovarian cancer treated with neoadjuvant pembrolizumab (pembro) + chemotherapy (chemo) ± anti–immunoglobulin-like transcript 4 (ILT4) monoclonal antibody MK-4830.
https://doi.org/10.1016/j.annonc.2025.11.020 Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer
https://doi.org/10.1136/ijgc-2023-esgo.776 #375 NETosis biomarkers levels in high-grade serous ovarian cancer patients’ biofluids: potential role in disease diagnosis and management
https://doi.org/10.1007/s00404-025-08098-0 Ectopic pregnancies: laparoscopic versus vNOTES approach. Surgical and obstetric outcomes
https://doi.org/10.1016/j.ijgc.2025.102117 Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches
https://doi.org/10.1016/j.ygyno.2025.04.505 Final overall survival analysis among patients with folate receptor alpha-positive, platinum-resistant ovarian cancer treated with mirvetuximab soravtansine versus investigator's choice chemotherapy in phase II MIRASOL (GOG-3045/ENGOT-ov55) study
https://doi.org/10.1080/01443615.2025.2564168 Shatavari ( Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study
https://doi.org/10.1111/apa.70404 Paediatric Primary Care Across Europe: A Survey of 42 Countries
https://doi.org/10.1016/j.ygyno.2026.01.777 Biomarker heterogeneity and efficacy of durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib in patients with mismatch repair proficient endometrial cancer: exploratory analyses of the DUO-E/GOG-3041/ENGOT-EN10 trial
https://doi.org/10.1089/clm.1996.14.137 The Effects of a Pulsed Nd:YAG Laser on Subgingival Bacterial Flora and on Cementum: An in Vivo Study
https://doi.org/10.1111/igc.0b013e3181a1ccfe Role of Diaphragmatic Surgery in 69 Patients With Ovarian Carcinoma
https://doi.org/10.1097/bsd.0b013e31820fc53b Cyclic Sciatica in a Patient With Deep Monolateral Endometriosis Infiltrating the Right Sciatic Nerve
Implementation of hysteroscopy in an infertility clinic: The one-stop uterine diagnosis and treatment.
https://doi.org/10.2147/amep.s162619 The role of smartphone game applications in improving laparoscopic skills
https://doi.org/10.1111/his.13711 Morphology and tumour‐infiltrating lymphocytes in high‐stage, high‐grade serous ovarian carcinoma correlated with long‐term survival
https://doi.org/10.1007/s00431-019-03523-4 Mandatory vaccination: a joint statement of the Ethics and Vaccination working groups of the European Academy of Paediatrics
https://doi.org/10.1016/j.jocn.2021.01.024 European women in neurosurgery: II – Historical characters and living legends
https://doi.org/10.1111/jpc.13020 Human papillomavirus vaccination crisis in Japan
https://doi.org/10.1007/s10397-016-0986-9 The role of video games in facilitating the psychomotor skills training in laparoscopic surgery
https://doi.org/10.1186/s10397-017-1031-3 A randomized control trial to evaluate the importance of pre-training basic laparoscopic psychomotor skills upon the learning curve of laparoscopic intra-corporeal knot tying
https://doi.org/10.1097/igc.0000000000001219 Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary Surgery
https://doi.org/10.1200/jco.2020.38.15_suppl.6039 Maintenance olaparib plus bevacizumab (bev) after platinum-based chemotherapy plus bev in patients (pts) with newly diagnosed advanced high-grade ovarian cancer (HGOC): Efficacy by BRCA1 or BRCA2 mutation in the phase III PAOLA-1 trial.
https://doi.org/10.1200/jco.2022.40.16_suppl.5511 Randomized phase III study of maintenance selinexor versus placebo in endometrial cancer (ENGOT-EN5/GOG-3055/SIENDO): Impact of subgroup analysis and molecular classification.
https://doi.org/10.1111/ejn.13236 Consensus Statement on European Brain Research: the need to expand brain research in Europe – 2015
https://doi.org/10.1016/j.jocn.2021.01.033 Four Athenas – Europe's first female neurosurgeons
https://doi.org/10.1200/jco.2021.39.15_suppl.5519 Molecular results and potential biomarkers identified from MILO/ENGOT-ov11 phase 3 study of binimetinib versus physicians choice of chemotherapy (PCC) in recurrent low-grade serous ovarian cancer (LGSOC).
https://doi.org/10.3389/fonc.2022.1021615 Cerebral glucose changes after chemotherapy and their relation to long-term cognitive complaints and fatigue
https://doi.org/10.1016/j.ejogrb.2022.03.010 Healthcare inequalities in antenatal care in the European Region: EBCOG Scientific review
https://doi.org/10.52054/fvvo.15.4.108 Perspectives in adhesion prevention in gynaecological surgery
https://doi.org/10.1136/ijgc-2021-esgo.656 1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO
https://doi.org/10.3389/fped.2023.1184870 Leave no one behind: why WHO's regional office for Europe should prioritise children and adolescents in their program of work. A position statement from the European academy of paediatrics
https://doi.org/10.1111/aogs.14811 Long‐term outcomes of children after prenatal exposure to maternal cancer and its treatment
https://doi.org/10.2217/fon-2023-0782 Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer – a plain language summary
https://doi.org/10.1016/j.annonc.2024.08.807 746P Phase III MIRASOL trial: Updated overall survival results of mirvetuximab soravtansine (MIRV) vs. investigator’s choice chemotherapy (ICC) in patients (pts) with platinum-resistant ovarian cancer (PROC) and high folate receptor-alpha (FRα) expression
https://doi.org/10.3390/cells13221904 Reduced Levels of miR-145-3p Drive Cell Cycle Progression in Advanced High-Grade Serous Ovarian Cancer
https://doi.org/10.1152/ajpcell.1993.264.3.c544 Staurosporine induced Ca2+ increase in DDT1MF-2 smooth muscle cells
https://doi.org/10.1038/sj.bjc.6601631 Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials
https://doi.org/10.1080/00015458.2004.11679550 Role of Surgery in Ovarian Cancer: An Update
https://doi.org/10.1186/s10397-017-1015-3 Dominant hand, non-dominant hand, or both? The effect of pre-training in hand-eye coordination upon the learning curve of laparoscopic intra-corporeal knot tying
https://doi.org/10.1016/j.ejogrb.2017.07.022 What European gynaecologists need to master: Consensus on medical expertise outcomes of pan-European postgraduate training in obstetrics & gynaecology
The European Academy laparoscopic "Suturing Training and Testing'' (SUTT) significantly improves surgeons' performance.